Share Wealth

Market
  • Markets Navigation
    Company Info.

    GlaxoSmithKline Pharmaceuticals Ltd.

    Investor Returns


    Market Cap.(`) 36060.62 Cr. P/BV 20.69 Book Value (`) 102.89
    52 Week High/Low ( ` ) 2524/1227 FV/ML 10/1 P/E(X) 58.47
    Book Closure 30/06/2023 EPS (`) 36.41 Div Yield (%) 1.50
    You can view dividend history of the company along with Bonus and Rights announcements.
    Rights Announcements
    YearRatioEx Right Date
    19931:55/21/1993
    Bonus Announcements
    YearRatioEx Bonus Date
    20181:19/11/2018
    19941:11/2/1995
    19801:3Nil
    Dividend Announcements
    Year - MonthDividend (%)
    2023 - 03320.00
    2022 - 03900.00
    2021 - 03300.00
    2020 - 03400.00
    2019 - 03200.00
    2018 - 03350.00
    2017 - 03300.00
    2016 - 03500.00
    2015 - 03625.00
    2013 - 12500.00
    2012 - 12500.00
    2011 - 12450.00
    2010 - 12400.00
    2009 - 12300.00
    2008 - 12400.00
    2007 - 12360.00
    2006 - 12310.00
    2005 - 12280.00
    2004 - 12240.00
    2003 - 12100.00
    2002 - 1270.00
    2001 - 1255.00
    2000 - 1250.00
    1999 - 1260.00
    1998 - 1250.00
    1997 - 1240.00
    1996 - 1240.00
    1995 - 12204.00
    1994 - 0640.00
    1993 - 0327.00
    1992 - 0318.00
    1991 - 0327.00
    1990 - 0327.00
    1989 - 0320.00

  • GlaxoSmithKline Pharmaceuticals Ltd.

    Live Quotes


    Registered Address
    Registered Office : GSK House, Dr. Annie Besant Road, Worli,
    Mumbai, Maharashtra - 400030
    Tel: 022-24959595
    Fax: 022-24959494
    Email : in.investorquery@gsk.com
    Website : http://www.gsk-india.com

    Key Officials
    NameDesignation
    Mr. A NadkarniCo. Secretary & Compl. Officer
    Mr. C SharmaExecutive Vice President - HR
    Mr. A KashyapVice President

    Listings
    BSE , MCXSX , NSE  

    Corporate News
    GlaxoSmithKline Phar - Disclosure Under Clause 30
    GlaxoSmithKline Phar - Updates
    GlaxoSmithKline Phar - Disclosure Under Regulation 30
    GlaxoSmithKline Phar - Board Meeting Intimation
    GlaxoSmithKline Phar - Board Meeting Intimation for \r\nAudi...
    GlaxoSmithKline Phar - Loss/Duplicate-Share Certificate-XBRL
    GlaxoSmithKline Phar - Loss of Share Certificates
    GlaxoSmithKline Phar - Loss/Duplicate-Share Certificate-XBRL
    GlaxoSmithKline Phar - Loss of Share Certificates
    GlaxoSmithKline Phar - Compliance Of Clause 40(9) Of The Lis...

    Board Meetings
    Date Purpose
    17/05/2024 Audited Results & Final Dividend
    12/02/2024 Quarterly Results
    09/11/2023 Quarterly Results

    Share Holding Pattern as on 31/03/2024
    Major Holder No. of Shares Percentage(%)
    Promoters 127,054,524 75.00
    Institutional Investors 19,271,956 11.38
    Other Investors 3,983,642 2.35
    General Public 19,095,912 11.27

    Registrar Details
    KFIN Technologies Pvt. Ltd.
    Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
    Hyderabad,500032,Telangana
    Tel : 040-67161500
    Fax : 23420814

    Today's Market

    Market Performance
    Exchange BSE NSE
    Last Traded Price ( ` ) 2,132.75 2,128.65
    Last Traded Date 26/04/2024 26/04/2024
    Last Traded Time 04:01:00 PM 04:02:42 PM
    Change (%) 3.26% 3.05%
    Day's Open ( ` ) 2,070.10 2,073.90
    Previous Close ( ` ) 2,065.40 2,065.60
    Day's High ( ` ) 2,145.75 2,148.00
    Day's Low ( ` ) 2,056.60 2,053.00
    Total Traded Qty 6612 228118
    Value ( ` In Lacs) 141.02 4831.95
    Bid Price ( ` ) 0.00 0.00
    Bid Quantity 0 0
    Offer Price ( ` ) 0 2,128.65
    Offer Quantity 0 15
    Exchange Code 500660 GLAXOEQ
    Exchange Group A OtherEQ
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html